BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 14605254)

  • 1. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
    Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
    Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.
    Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H
    J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.
    Weiss JM; König SJ; Polack S; Emons G; Schulz KD; Diedrich K; Ortmann O
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):118-26. PubMed ID: 16891115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist.
    Mo Y; Peng P; Zhou R; He Z; Huang L; Yang D
    Reprod Sci; 2010 Jan; 17(1):68-77. PubMed ID: 19861704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
    Roth CL; Brendel L; Rückert C; Hartmann K
    Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.
    Horvath JE; Bajo AM; Schally AV; Kovacs M; Herbert F; Groot K
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15048-53. PubMed ID: 12409615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GnRH antagonist cetrorelix prevents sexual maturation of peripubertal male rats.
    Roth C; Leonhardt S; Seidel C; Lakomek M; Wuttke W; Jarry H
    Exp Clin Endocrinol Diabetes; 2000; 108(5):358-63. PubMed ID: 10989955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of agonistic vs. antagonistic gnrh-analogues (triptorelin vs. cetrorelix) on bone modeling and remodeling in peripubertal female rats.
    Roth CL; Neu C; Jarry H; Schoenau E
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):451-6. PubMed ID: 16151979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.
    Kovacs M; Schally AV
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12197-202. PubMed ID: 11593037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV
    Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.
    Lerrant Y; Kottler ML; Bergametti F; Moumni M; Blumberg-Tick J; Counis R
    Endocrinology; 1995 Jul; 136(7):2803-8. PubMed ID: 7789305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone receptor gene expression during pubertal development of female rats.
    Zapatero-Caballero H; Sanchez-Franco F; Fernandez-Mendez C; García-San Frutos M; Botella-Cubells LM; Fernandez-Vazquez G
    Biol Reprod; 2004 Feb; 70(2):348-55. PubMed ID: 14561652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist.
    Dong M; Huang L; Wang W; Du M; He Z; Mo Y; Yang D
    Pharmazie; 2011 Jun; 66(6):436-9. PubMed ID: 21699083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects.
    Murase M; Uemura T; Gao M; Inada M; Funabashi T; Hirahara F
    Endocr J; 2005 Feb; 52(1):131-7. PubMed ID: 15758569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats.
    Horvath JE; Toller GL; Schally AV; Bajo AM; Groot K
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4996-5001. PubMed ID: 15044692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cetrorelix, a GnRH-receptor antagonist, on gonadal axis in women with functional hypothalamic amenorrhea.
    Berardelli R; Gianotti L; Karamouzis I; Picu A; Giordano R; D'Angelo V; Zinnà D; Lanfranco F; Ghigo E; Arvat E
    Gynecol Endocrinol; 2011 Oct; 27(10):753-8. PubMed ID: 21204607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing hormone-releasing hormone antagonist Cetrorelix regulates the expression of Galphas and Galphai protein subunits and adenylate cyclase activity in rat ovary, breast and pituitary.
    Collado B; Carmena MJ; Cortés J; Schally AV; Prieto JC
    Int J Oncol; 2004 Mar; 24(3):725-30. PubMed ID: 14767559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.